bpc-157 human clinical trial case report The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety BPC-157 Oral vs Injection: Benefits,
Description
10.1021/acs.molpharmaceut.3c00769 [DOI] [PMC free article] [PubMed] [Google Scholar] Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T
Bei schwerer Niereninsuffizienz, unbehandelten Herz-Kreislauf-Erkrankungen oder unklarer maligner Vorgeschichte ist die Anwendung nicht empfohlen
No, PDA is not a substitute for medically prescribed treatments or pain management protocols
Its encouraging but not conclusive
